Aurohealth LLC commenced operations in May 2012 and is a wholly owned subsidiary of AurobindoUSA, which is responsible for generic pharmaceutical products in the USA. Aurohealth leverages the development, API, and finished product manufacturing strengths and resources of our parent company augmented by a team of generic industry-seasoned professionals who possess the industry knowledge and experience, and relationships to create a company with a very broad, unique product portfolio.
Aurohealth LLC is a pharmaceutical company that develops, manufactures, markets and distributes store brand Over the Counter (OTC) products. Our mission is to develop as many OTC products for the US retail market providing a consistent and reliable supply, at a fair price, and of the highest quality. We are very customer focused organization that continuously seeks ways to be a reliable source for our customer’s needs.
Our targets include Rx to OTC switch molecules, ANDA & Monograph OTC products in various dosage forms / formats solids (tablets, capsules, soft gels), liquids, semi solids & nasal sprays. Our FDA approved manufacturing sites are located in USA & India.
Lawrenceville, NJ– Liquids, semi solids & nasal sprays – 52 million units / year. We have over 200,000 square feet of packaging & distribution space for solids & liquids at this facility.
Dayton, NJ– Solids including DEA controlled products – 3 billion doses / year.
Hyderabad, India– Solids – 8 billion doses / year.